Skip to main content

Geode Capital Management, LLC

SEC CIK
0001214717
Latest filing
Aug 12, 2026

IGMS holding history

IGM Biosciences, Inc. in every 13F filed by Geode Capital Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

IGMS overviewAll 13F holders of IGMSFull Q2 2026 holdings

Shares (Q3 2025)
0
Sold out in Q3 2025
Value
$0
% of portfolio
0.0%
Quarters held
18
Since Q1 2021
Holdings of IGMS by Geode Capital Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20250$00.0%−213,273−100.0%Sold outHolders
Q2 2025213,273$239.0K<0.1%−212,387−49.9%ReducedHolders
Q1 2025425,660$489.7K<0.1%+16,527+4.0%AddedHolders
Q4 2024409,133$2.50M<0.1%+13,334+3.4%AddedHolders
Q3 2024395,799$6.55M<0.1%+28,118+7.6%AddedHolders
Q2 2024367,681$2.53M<0.1%+31,676+9.4%AddedHolders
Q1 2024336,005$3.24M<0.1%+9,349+2.9%AddedHolders
Q4 2023326,656$2.71M<0.1%+34,124+11.7%AddedHolders
Q3 2023292,532$2.44M<0.1%+72,115+32.7%AddedHolders
Q2 2023220,417$2.03M<0.1%+22,360+11.3%AddedHolders
Q1 2023198,057$2.72M<0.1%+4,307+2.2%AddedHolders
Q4 2022193,750$3.29M<0.1%+10,735+5.9%AddedHolders
Q3 2022183,015$4.16M<0.1%−13,695−7.0%ReducedHolders
Q2 2022196,710$3.55M<0.1%−17,572−8.2%ReducedHolders
Q1 2022214,282$5.73M<0.1%+69,101+47.6%AddedHolders
Q4 2021145,181$4.26M<0.1%−8,218−5.4%ReducedHolders
Q3 2021153,399$10.1M<0.1%+8,390+5.8%AddedHolders
Q2 2021145,009$12.1M<0.1%+8,943+6.6%AddedHolders
Q1 2021136,066$10.4M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.